S07-2010 | pan-AKR1C inhibitor

CAS:
 1223194-71-5
Catalog Number:
 10-4148

Available Options

Size:PriceQuantity 
5 mg$80.00
25 mg$270.00

S07-2010 (1223194-71-5) is a pan-aldo-keto reductase 1C (AKR1C) inhibitor (IC50’s for AKR1C isoforms: 1C1 = 470 nM, 1C2 = 730 nM, 1C3 = 190 nM, 1C4 = 360 nM).  Dysregulated AKR1C3 expression (and overexpression of all AKR1C isoforms in general) is related to resistance to radio- and chemotherapy in various tumor types and is associated with development of and poor prognosis in many cancers.  S07-2010 displayed cytotoxicity to doxorubicin-resistant MCF-7 cells (IC50 = 127.5 µM) and cisplatin-resistant A549 cells (IC50 = 5.51 µM).  Combination treatment of chemotherapeutic agents and S07-2010 showed synergistic effects in drug-resistant cell lines.

References/Citations:

  1. He et al. (2022), Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance; ACS Med. Chem. Lett. 13 1286
CAS:
1223194-71-5
Catalog Number:
10-4148
Activity:
pan-AKR1C inhibitor
Chemical Names:
7-(2-((6-Oxo-4-propyl-1,6-dihydropyrimidin-2-yl)thio)acetyl)-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one
Molecular Weight:
371.46
Molecular Formula:

C19H21N3O3S

Solubility:
Soluble in DMSO (50 mg/ml)
Physical Properties:
Off-white solid
Purity:

98% by TLC NMR: (Conforms)

Storage Temperature:
-20°C
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Shipping Code:
RT

Safety Data Sheet:

N/A

Product Data Sheet:

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee